CRMD 8-K 2026-11-02

CorMedix Inc. (CRMD) 8-K dated 2026-11-02 — accession 0001213900-26-114665.

CorMedix Inc. (CRMD) is a biotechnology company listed on US.

CRMD: SECURITIES AND EXCHANGE COMMISSION

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRMD revenue for 2025-12-31 was $311.7M. Net income was $163.1M. Revenue was up 617.0% from 2024-12-31 to 2025-12-31. CRMD currently screens at market cap $655.9M.

Not investment advice. The CRMD SEC hub lists recent forms. The stock page is the research view.